SECURITIES AND EXCHANGE COMMISSION

                     Washington, D.C. 20549

                          Schedule 13G


           Under the Securities Exchange Act of 1934
                       (Amendment No. 3)*


                 INHALE THERAPEUTIC SYSTEMS, INC.
            _______________________________________
                        (Name of Issuer)



                          Common Stock
            _______________________________________
                 (Title of Class of Securities)



                           457191104
            _______________________________________
                         (CUSIP Number)


Check the following box if a fee is being paid with this
statement ____.  (A fee is not required only if the filing
person: (1) has a previous statement on file reporting beneficial
ownership of more than five percent of the class of securities
described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of
such class.)  (See Rule 13d-7.)

*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.

The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).

                (Continued on following page(s))

                       Page 1 of 6 Pages
CUSIP NO. 457191104        13G             Page 2 of 6 Pages

1  Name of Reporting Person
   S.S. or I.R.S. Identification No. of Above Person

   T. ROWE PRICE ASSOCIATES, INC.
   52-0556948

2  Check the Appropriate Box if a Member of a Group*

                                                       (a) ____
   NOT APPLICABLE                                      (b) ____

3  SEC Use Only

   ______________________________

4  Citizenship or Place of Organization

   MARYLAND

Number of      5  Sole Voting Power
               **
Shares            273,100

Beneficially   6  Shared Voting Power
               **
Owned By Each     NONE

Reporting      7  Sole Dispositive Power
               **
Person            1,382,650

With           8  Shared Dispositive Power

                  NONE

9  Aggregate Amount Beneficially Owned by Each Reporting Person

   1,382,650

10 Check Box if the Aggregate Amount in Row (9) Excludes Certain
   Shares*

   NOT APPLICABLE

11 Percent of Class Represented by Amount in Row 9

   6.6%

12 Type of Reporting Person*

   IA
              *SEE INSTRUCTION BEFORE FILLING OUT!
        **Any shares reported in Items 5 and 6 are also
                      reported in Item 7.
CUSIP NO. 457191104             13G             Page 3 of 6 Pages

1  Name of Reporting Person
   S.S. or I.R.S. Identification No. of Above Person

   T. ROWE PRICE NEW HORIZONS FUND, INC.
   52-0791372

2  Check the Appropriate Box if a Member of a Group*

                                                       (a) ____
   NOT APPLICABLE                                      (b) ____

3  SEC Use Only

   ______________________________

4  Citizenship or Place of Organization

   Maryland

Number of      5  Sole Voting Power
               **
Shares            725,000

Beneficially   6  Shared Voting Power
               **
Owned By Each     NONE

Reporting      7  Sole Dispositive Power
               **
Person            NONE

With           8  Shared Dispositive Power

                  NONE

9  Aggregate Amount Beneficially Owned by Each Reporting Person

   725,000

10 Check Box if the Aggregate Amount in Row (9) Excludes Certain
   Shares*

   NOT APPLICABLE

11 Percent of Class Represented by Amount in Row 9

   3.4%

12 Type of Reporting Person*

   IV
              *SEE INSTRUCTION BEFORE FILLING OUT!
**The aggregate amount reported on this page is also included in
the aggregate amount reported by T. Rowe Price Associates, Inc.
on page 2 of this Schedule 13G.
SCHEDULE 13G
PAGE 4 OF 6

Item 1(a) Name of Issuer:

          Reference is made to page 1 of this Schedule 13G

Item 1(b) Address of Issuer's Principal Executive Offices:

          150 Industrial Road, San Carlos, California 94070


Item 2(a) Name of Person(s) Filing:

          (1)  T. Rowe Price Associates, Inc. ("Price
               Associates")

          (2)  T. Rowe Price New Horizons Fund, Inc.

   X      Attached as Exhibit A is a copy of an agreement between
the Persons Filing (as specified hereinabove) that this
Schedule 13G is being filed on behalf of each of them.

Item 2(b) Address of Principal Business Office:

          100 E. Pratt Street, Baltimore, Maryland 21202

Item 2(c) Citizenship or Place of Organization:

          (1)  Maryland

          (2)  Maryland

Item 2(d) Title of Class of Securities:

          Reference is made to page 1 of this Schedule 13G

Item 2(e) CUSIP Number: 457191104


Item 3    The person filing this Schedule 13G is an:

  X       Investment Adviser registered under Section 203 of the
          Investment Advisers Act of 1940

  X       Investment Company registered under Section 8 of the
          Investment Company Act of 1940


Item 4    Reference is made to Items 5-11 on page 2 of this
          Schedule 13G.
SCHEDULE 13G                                      PAGE 5 OF 6

Item 5  Ownership of Five Percent or Less of a Class.

        This statement is being filed to report the fact that,
        as of the date of this report, T. Rowe Price New
        Horizons, Fund has ceased to be the beneficial owner of
        more than five percent of the class of securities.

        This Item 5 is not applicable with respect to Price
        Associates.

Item 6  Ownership of More than Five Percent on Behalf of Another
        Person

        (1) Price Associates does not serve as custodian of the
            assets of any of its clients; accordingly, in each
            instance only the client or the client's custodian
            or trustee bank has the right to receive dividends
            paid with respect to, and proceeds from the sale of,
            such securities.

            The ultimate power to direct the receipt of
            dividends paid with respect to, and the proceeds
            from the sale of, such securities, is vested in the
            individual and institutional clients which Price
            Associates serves as investment adviser.  Any and
            all discretionary authority which has been delegated
            to Price Associates may be revoked in whole or in
            part at any time.

            Except as may be indicated if this is a joint filing
            with one of the registered investment companies
            sponsored by Price Associates which it also serves
            as investment adviser ("T. Rowe Price Funds"), not
            more than 5% of the class of such securities is
            owned by any one client subject to the investment
            advice of Price Associates.

        (2) With respect to securities owned by any one of the
            T. Rowe Price Funds, only State Street Bank and
            Trust Company, as custodian for each of such Funds,
            has the right to receive dividends paid with respect
            to, and proceeds from the sale of, such securities.
            No other person is known to have such right, except
            that the shareholders of each such Fund participate
            proportionately in any dividends and distributions
            so paid.

Item 7  Identification and Classification of the Subsidiary
        Which Acquired the Security Being Reported on By the
        Parent Holding Company.

        Not Applicable.

Item 8  Identification and Classification of Members of the
        Group.

        Not Applicable.
SCHEDULE 13G
PAGE 6 OF 6


Item 9   Notice of Dissolution of Group.

         Not Applicable.


Item 10  Certification.

         By signing below I (we) certify that, to the best of my
         (our) knowledge and belief, the securities referred to
         above were acquired in the ordinary course of business
         and were not acquired for the purpose of and do not have
         the effect of changing or influencing the control of the
         issuer of such securities and were not acquired in
         connection with or as a participant in any transaction
         having such purpose or effect.  T. Rowe Price
         Associates, Inc. hereby declares and affirms that the
         filing of Schedule 13G shall not be construed as an
         admission that Price Associates is the beneficial owner
         of the securities referred to, which beneficial
         ownership is expressly denied.

                           Signature.

         After reasonable inquiry and to the best of my (our)
         knowledge and belief, I (we) certify that the
         information set forth in this statement is true,
         complete and correct.


Dated: July 10, 2000               Dated: July 10, 2000


T. ROWE PRICE NEW HORIZONS         T. ROWE PRICE ASSOCIATES, INC.
        FUND, INC.



By: /s/ Joseph A. Carrier          By: /s/ Henry H. Hopkins
    Joseph A. Carrier,                 Henry H. Hopkins,
    Treasurer                          Managing Director


Note:    This Schedule 13G, including all exhibits, must be filed
         with the Securities and Exchange Commission, and a copy
         hereof must be sent to the issuer by registered or
         certified mail not later than February 14th following
         the calendar year covered by the statement or within the
         time specified in Rule 13d-1(b)(2), if applicable.

06/30/2000
EXHIBIT A


                           AGREEMENT

                  JOINT FILING OF SCHEDULE 13G


     T. Rowe Price Associates, Inc. (an investment adviser
registered under the Investment Advisers Act of 1940) and T. Rowe
Price New Horizons Fund, Inc., a Maryland corporation, hereby
agree to file jointly the statement on Schedule 13G to which this
Agreement is attached, and any amendments thereto which may be
deemed necessary, pursuant to Regulation 13D-G under the
Securities Exchange Act of 1934.

     It is understood and agreed that each of the parties hereto
is responsible for the timely filing of such statement and any
amendments thereto, and for the completeness and accuracy of the
information concerning such party contained therein, but such
party is not responsible for the completeness or accuracy of
information concerning the other party unless such party knows or
has reason to believe that such information is inaccurate.

     It is understood and agreed that a copy of this Agreement
shall be attached as an exhibit to the statement on Schedule 13G,
and any amendments hereto, filed on behalf of each of the parties
hereto.


Dated: July 10, 2000               Dated: July 10, 2000


T. ROWE PRICE NEW HORIZONS         T. ROWE PRICE ASSOCIATES, INC.
        FUND, INC.



By: /s/ Joseph A. Carrier          By: /s/ Henry H. Hopkins
    Joseph A. Carrier,                 Henry H. Hopkins,
    Treasurer                          Managing Director